Chembio Diagnostics, Inc. (NASDAQ: CEMI) announced today the pricing of its previously announced underwritten registered public offering of 1,783,760 shares ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE